catheterization

导管插入术
  • 文章类型: Journal Article
    在过去的五十年里,Fontan手术已被开发用于改善以功能性单心室为特征的先天性心脏缺陷患者的预期寿命。Fontan循环旨在在没有推动的肺动脉下心室的情况下将全身静脉回流重定向到肺循环。这使得这种生理非常脆弱,并导致一些长期并发症。尽管通过心导管插入术进行血流动力学评估在这些患者的管理和随访中很重要,缺乏对这种循环的最终功能的透彻理解,血液动力学数据的解释通常很复杂。近年来,新的工具,如联合导管插入术和心肺运动试验,以提高对这些患者的血流动力学特征的了解。此外,已经开发了广泛的经皮治疗选择,解决从Fontan途径的阻塞性问题和通过代偿侧支的获得性分流到淋巴循环障碍的经皮治疗和房室瓣的经导管边缘到边缘修复等问题。这篇综述的目的是详细介绍Fontan循环患者心导管插入术中使用的各种工具,分析不同的经皮治疗策略,并讨论该领域的最新进展。
    Over the past five decades, the Fontan procedure has been developed to improve the life expectancy of patients with congenital heart defects characterized by a functionally single ventricle. The Fontan circulation aims at redirecting systemic venous return to the pulmonary circulation in the absence of an impelling subpulmonary ventricle, which makes this physiology quite fragile and leads to several long-term complications. Despite the importance of hemodynamic assessment through cardiac catheterization in the management and follow-up of these patients, a thorough understanding of the ultimate functioning of this type of circulation is lacking, and the interpretation of the hemodynamic data is often complex. In recent years, new tools such as combined catheterization with cardiopulmonary exercise testing have been incorporated to improve the understanding of the hemodynamic profile of these patients. Furthermore, extensive percutaneous treatment options have been developed, addressing issues ranging from obstructive problems in Fontan pathway and acquired shunts through compensatory collaterals to the percutaneous treatment of lymphatic circulation disorders and transcatheter edge-to-edge repair of atrioventricular valves. The aim of this review is to detail the various tools used in cardiac catheterization for patients with Fontan circulation, analyze different percutaneous treatment strategies, and discuss the latest advancements in this field.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    评估多次单插管技术(MUST)对动静脉移植物(AVG)结局的影响。
    对2018年1月至2021年12月在郑州大学第一附属医院创建的AVG进行了回顾性研究。分析患者的临床资料及其静脉通路的随访资料。根据是否使用MUST将受试者分为MUST组和非MUST组。比较两组患者的累积通畅率和并发症发生率。采用Logistic回归分析AVG应用MUST的影响因素。
    必须组包括115AVG和非必须组,122AVG。1年,2年,3年,MUST组的4年累积通畅率为100%,99.1%,95.2%,85.4%,73.2%,分别,而非必须组则为97.5%,92.7%,77.7%,69.7%,50.0%,分别,2年和3年通畅率差异有统计学意义(P=0.022,P=0.004)。MUST组以(中位数[四分位距])表示的标准干预率明显低于非MUST组(0.46[0.00,0.94]vs.0.97[0.60,1.59],Z=-5.808,P<0.001)。MUST组共24例(20.9%)AVG和非MUST组60例(49.2%)AVG的标准干预率>1.0/患者年,两组之间具有显著差异。MUST组有3例(2.6%)AVG,非MUST组有7例(5.7%)AVG合并动脉瘤(χ2=20.737,P<0.001)。MUST组1例(0.9%)AVG和非MUST组6例(4.9%)AVG有移植物感染,组间差异无统计学意义(P=0.121)。多因素logistic回归显示联盟设施透析(比值比[OR]=2.713,95%置信区间[CI]:1.698-4.336,P<0.001],随访良好[OR=2.189,95%CI:1.221~3.927,P=0.009]是AVG应用MUST的影响因素。
    必须改善AVG的累积通畅性,并在不增加移植物感染风险的情况下降低介入频率和动脉瘤的发生率。
    UNASSIGNED: To evaluate the effects of the multiple single cannulation technique (MUST) on the outcomes of arteriovenous graft (AVG).
    UNASSIGNED: A retrospective study of AVG created between January 2018 and December 2021 at the First Affiliated Hospital of Zhengzhou University was conducted. The clinical data of patients and their follow-up data for venous access were analyzed. Subjects were divided into the MUST group or the non-MUST group according to whether MUST was used. The cumulative patency rate and complication incidence were compared between the two groups. Logistic regression was applied to analyze the influencing factors of applying MUST in AVG.
    UNASSIGNED: The MUST group included 115 AVG and the non-MUST group, 122 AVG. The 1-year, 2-year, 3-year, and 4-year cumulative patency rates of the MUST group were 100%, 99.1%, 95.2%, 85.4%, and 73.2%, respectively, while those for the non-MUST group were 97.5%, 92.7%, 77.7%, 69.7%, and 50.0%, respectively, with the 2-year and 3-year patency rates showing significant difference (P=0.022, P=0.004). The standard intervention rate expressed in (median [interquartile range]) in the MUST group was significantly lower than that in the non-MUST group (0.46 [0.00, 0.94] vs. 0.97 [0.60, 1.59], Z=-5.808, P<0.001). A total of 24 (20.9%) AVG in the MUST group and 60 (49.2%) AVG in the non-MUST group had a standard intervention rate >1.0 per patient-year, with significant difference between the two groups. Three (2.6%) AVG in the MUST group and 7 (5.7%) AVG in the non-MUST group were complicated by aneurysm (χ 2=20.737, P<0.001). One (0.9%) AVG in the MUST group and 6 (4.9%) AVG in the non-MUST group had graft infection, with the difference between the groups showing no significance (P=0.121). Multivariate logistic regression showed that dialysis in the alliance facilities (odds ratio [OR]=2.713, 95% confidence interval [CI]: 1.698-4.336, P<0.001], and excellent follow-up [OR=2.189, 95% CI: 1.221-3.927, P=0.009] were the influencing factors of applying MUST in AVG.
    UNASSIGNED: MUST improves the cumulative patency of AVG and decreases the intervention frequency and the incidence of aneurysm without increasing the risk of graft infection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    比较无导尿管(TWOC)立即试验后建立自发性排尿的成功与男性急性尿retention留的延迟性TWOC。
    在这篇系统综述中,我们纳入了报告在≥18岁男性因急性尿潴留而插管的即时TWOC或延迟TWOC(≤30天)成功率的研究.我们排除了耻骨上导管插入术的研究,术后/围手术期导尿和与创伤相关的尿潴留。我们搜索了以下数据库:MEDLINE,Embase,Cochrane系统评价数据库,Cochrane中央控制试验登记册,打开灰色和Clinicaltrials.gov.搜索于2022年11月30日结束。语言或发布日期没有限制。使用ROB2.0和ROBINS-I工具评估偏倚风险。我们进行了随机效应限制的最大似然模型荟萃分析。使用等级评估证据的确定性。
    我们纳入了61项研究。在两项随机对照试验(RCT)中,都有一些对偏见风险的担忧,包括总共174名参与者,相对成功率为1.22(95%CI0.84-1.76),有利于延迟TWOC。在两项比较队列研究中,两者都有严重的偏见风险,包括642名参与者,相对成功率为1.18(0.94-1.47),有利于延迟TWOC。一项研究由于质量极低而被排除在该荟萃分析之外。四项研究报告了即时TWOC队列的成功率,都有严重的偏见风险,包括409名参与者,总体成功率为47%(29-66)。52项研究报告了TWOC延迟队列的成功率,都有严重的偏见风险,包括12489名参与者,总体成功率为53%(49-56)。证据的确定性被认为是低的RCT和非常低的其余部分。
    有有限数量的适当设计的研究直接解决研究问题。证据都不赞成这两种方法。
    UNASSIGNED: To compare the success of establishing spontaneous micturition following immediate trial without catheter (TWOC) to delayed TWOC in males catheterized for acute urinary retention.
    UNASSIGNED: In this systematic review, we included studies reporting success rates of immediate TWOC or delayed TWOC (≤30 days) among males ≥18 years of age catheterized for acute urinary retention. We excluded studies on suprapubic catheterization, postoperative/perioperative catheterization and urinary retention related to trauma. We searched the following databases: MEDLINE, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Open Grey and Clinicaltrials.gov. The search was concluded on 30 November 2022. There were no restrictions on language or publication date. Risk of bias was assessed using the ROB 2.0 and ROBINS-I tools. We did random-effects restricted maximum likelihood model meta-analyses. Certainty of evidence was assessed using GRADE.
    UNASSIGNED: We included 61 studies. In two randomized controlled trials (RCTs), both with some concerns for risk of bias, including in total 174 participants, the relative success rate was 1.22 (95% CI 0.84-1.76) favouring delayed TWOC. In two comparative cohort studies, both with serious risk of bias, including 642 participants, the relative success rate was 1.18 (0.94-1.47) favouring delayed TWOC. One study was excluded from this meta-analysis because of critically low quality. Four studies reporting success rates for cohorts with immediate TWOC, all with serious risk of bias, including 409 participants, had an overall success rate of 47% (29-66). Fifty-two studies reporting success rates for cohorts with delayed TWOC, all with serious risk of bias, including 12 489 participants, had an overall success rate of 53% (49-56). The certainty of the evidence was considered low for the RCTs and very low for the rest.
    UNASSIGNED: There was a limited number of appropriately designed studies addressing the research question directly. The evidence favours neither approach.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    通过右颈内静脉(RIJV)将电极导管插入冠状窦(CS)会导致气胸和严重血肿形成。进行这项研究是为了比较通过左肘浅静脉与RIJV进行导管插入的安全性和可行性。
    这项前瞻性非随机研究涉及2021年9月至2023年2月连续接受导管消融的患者。左肘静脉组采用盲穿刺技术;RIJV组采用超声引导下插入。鞘管插入和CS导管插入的成功率,CS插管的程序和透视次数,比较两组并发症发生情况。
    左肘静脉组包括152名患者,RIJV组包括58例患者。肘静脉组的鞘插入成功率明显低于RIJV组(84.9%vs100%,分别为;p=.0008)。在肘静脉组,20例患者的盲穿刺尝试失败;3例患者发生导丝引起的静脉损伤.RIJV组发生1次动脉穿刺。成功插入护套后,CS插管成功率无显著差异(97%vs100%,p=.55),手术时间(中位数[范围],93[51-174]vs74[44-129]s;p=.19),或透视时间(中位数[范围],66[36-134]vs48[30-92]s;p=.17)。没有发生需要停止手术的严重并发症。
    左肘静脉入路是实用的,为RIJV方法提供可行的替代方案。
    UNASSIGNED: Insertion of electrode catheters into the coronary sinus (CS) through the right internal jugular vein (RIJV) carries risks of pneumothorax and severe hematoma formation. This study was performed to compare the safety and feasibility of catheterization through the left cubital superficial vein versus the RIJV.
    UNASSIGNED: This prospective nonrandomized study involved consecutive patients who underwent catheter ablation from September 2021 to February 2023. Blind puncture techniques were used in the left cubital vein group; ultrasound-guided insertion was performed in the RIJV group. The success rates of sheath insertion and CS catheterization, the procedure and fluoroscopy times of CS cannulation, and complications were compared between groups.
    UNASSIGNED: The left cubital vein group comprised 152 patients, and the RIJV group comprised 58 patients. The sheath insertion success rate was significantly lower in the cubital vein group than in the RIJV group (84.9% vs 100%, respectively; p = .0008). In the cubital vein group, blind puncture attempts failed in 20 patients; three patients developed guidewire-induced venous injury. One arterial puncture occurred in the RIJV group. After successful sheath insertion, no significant differences were observed in the CS cannulation success rate (97% vs 100%, p = .55), procedure time (median [range], 93 [51-174] vs 74 [44-129] s; p = .19), or fluoroscopy time (median [range], 66 [36-134] vs 48 [30-92] s; p = .17). No serious complications requiring procedural discontinuation occurred.
    UNASSIGNED: The left cubital vein approach is practical, offering a viable alternative to the RIJV approach.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    动脉导管未闭(PDA)的封堵器正在迅速发展,AmplatzerPiccolo封堵器(Abbott)获得美国食品和药物管理局的批准,并成为首个被批准用于≥700g患者的PDA封堵的装置。我们报告了早产儿在Piccolo封堵PDA后出现的首例完全左肺动脉(LPA)封堵的已知病例。
    PDA关闭的回顾性图表分析。
    在过去2年中,我们在早产新生儿中进行了50多例Piccolo装置封堵PDA,这2例代表我们唯一的并发症(4%)。这表示总并发症发生率与已发布此手术数据的大多数中心相似或更低。
    虽然罕见,在PDA封堵装置后,早产儿出现严重的LPA梗阻.Piccolo装置被设计为理想地完全保持在导管内。虽然我们的设备选择似乎提供了一个足够短的设备,对于给定的导管长度,我们建议,只要有可能,考虑使用尽可能短的设备。如果在任何时候影像学显示阻塞/湍流程度增加,我们还建议将超声心动图监测的频率增加到每周研究。
    UNASSIGNED: Device closure of a patent ductus arteriosus (PDA) is rapidly evolving, with the Amplatzer Piccolo Occluder (Abbott) receiving US Food and Drug Administration approval and becoming the first device approved for PDA closure in patients ≥700 g. We report on the first known cases of complete left pulmonary artery (LPA) occlusion following Piccolo closure of a PDA in premature infants.
    UNASSIGNED: Retrospective chart analysis of PDA closures.
    UNASSIGNED: We have performed over 50 cases of Piccolo device closure of the PDA in preterm neonates in the past 2 years, with these 2 cases representing our only complications (4%). This represents a total complication rate similar to or lower than most centers that have published data for this procedure.
    UNASSIGNED: Although rare, severe LPA obstruction can be seen in premature infants following device closure of the PDA. The Piccolo device is designed to ideally remain entirely intraductal. Although our device selection appeared to provide a device short enough for the given ductal length, we recommend, whenever possible, giving consideration to using the shortest possible device. We also recommend increasing the frequency of echocardiographic surveillance to weekly studies if at any time the imaging demonstrates an increase in the degree of obstruction/turbulence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    我们的目标是在OpSensOptoWireIII及其新的专有TAVR算法与导管插入术和超声心动图(经胸超声心动图和经食道超声心动图)得出的血液动力学值之间建立与经导管主动脉瓣置换术(TAVR)期间梯度测量相关的一致性程度。
    当前的研究是前瞻性的,单臂,单中心研究。所有受试者在TAVR之前和之后都进行了血液动力学评估,使用标准的血液动力学评估,使用2根辫子,经胸超声心动图,经食管超声心动图,和OpSensOptoWireIII。主要终点是OpSensOptoWireIII与导管插入术得出的血液动力学值之间的最终TAVR后平均梯度相关性。
    在2021年7月至2021年9月之间,招募了20名患者。中位年龄为79[6.5]岁,9(45%)患者为女性。通过2-pigtail技术得出的TAVR之前的平均梯度与使用OpSensOptoWireIII的平均梯度相似(35±14mmHgvs35±14mmHg,P=1.00),绝对平均差为2.2±3.5mmHg,具有很强的相关性(r=0.96,P<.0001)。在TAVR之后,2-pigtail技术得出的平均梯度和使用OpSensOptoWireIII的平均梯度相似(2.2±3.5vs2.8±2.7,P=.16),绝对平均差为1.2±1.3mmHg,具有很强的相关性(r=0.89,P<.0001)。
    由OpSensOptoWireIII导线及其新的TAVR算法得出的血液动力学评估与TAVR之前和之后的2根光纤得出的测量值具有极好的相关性。将这项新技术集成到具有实时血液动力学评估的专用TAVR线中,可以为TAVR操作员带来有意义的价值。
    UNASSIGNED: We aim to establish the degree of agreement related to gradient measurement during transcatheter aortic valve replacement (TAVR) between the OpSens OptoWire III and its new proprietary TAVR algorithm and hemodynamic value derived by catheterization and echocardiogram (transthoracic echocardiogram and transesophageal echocardiogram).
    UNASSIGNED: The current study was a prospective, single-arm, single-center study. All subjects underwent hemodynamic assessment before and after TAVR using standard hemodynamic assessment using 2 pigtails, transthoracic echocardiogram, transesophageal echocardiogram, and the OpSens OptoWire III. The primary end point was the final post-TAVR mean gradient correlation between OpSens OptoWire III and hemodynamic values derived by catheterization.
    UNASSIGNED: Between July 2021 and September 2021, 20 patients were enrolled. The median age was 79 [6.5] years, and 9 (45%) patients were female. The mean gradient before TAVR derived by 2-pigtail technique and the mean gradient using the OpSens OptoWire III were similar (35 ± 14 mm Hg vs 35 ± 14 mm Hg, P = 1.00), with an absolute mean difference of 2.2 ± 3.5 mm Hg and a strong correlation (r = 0.96, P < .0001). After TAVR, the mean gradient derived by 2-pigtail technique and the mean gradient using the OpSens OptoWire III were similar (2.2 ± 3.5 vs 2.8 ± 2.7, P = .16), with an absolute mean difference of 1.2 ± 1.3 mm Hg and a strong correlation (r = 0.89, P < .0001).
    UNASSIGNED: Hemodynamic assessment derived by the OpSens OptoWire III wire and its new TAVR algorithm demonstrated excellent correlation with measurements derived by 2 pigtails both before and after TAVR. Integration of this new technology within a dedicated TAVR wire with live hemodynamic assessment could bring meaningful value to TAVR operators.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:脑灌注可能根据动脉插管部位而变化,并可能影响心脏切开术后体外生命支持(ECLS)中神经系统不良事件的发生率。当前的研究将患者的神经系统结局与三种常用的动脉插管策略进行了比较(主动脉与锁骨下/腋窝vs.股动脉),以评估每种ECLS配置是否与神经系统并发症的不同发生率相关。
    方法:本回顾性研究,多中心(34个中心),观察性研究纳入了2000年1月至2020年12月期间需要进行心脏切开术后ECLS的成年人,该研究出现在心脏切开术后体外生命支持(PELS)研究数据库中.主动脉患者,比较锁骨下/腋下和股骨插管在复合神经系统终点(缺血性卒中,脑出血,脑水肿)。次要结局是总体住院死亡率,神经系统并发症是院内死亡的原因,和术后轻微的神经系统并发症(癫痫发作)。通过线性混合效应模型研究了插管与神经系统结局之间的关联。
    结果:这项研究包括1897名患者,其中主动脉占26.5%(n=503),20.9%锁骨下/腋下(n=397)和52.6%股骨(n=997)插管。锁骨下/腋下组的高血压病史更为频繁,吸烟,糖尿病,以前的心肌梗塞,透析,外周动脉疾病和既往卒中。神经监测在所有组中都很少使用。在混合效应模型调整后,锁骨下/腋下的主要神经系统并发症更为常见(主动脉:n=79,15.8%;锁骨下/腋下:n=78,19.6%;股骨:n=118,11.9%;p<0.001)(OR1.53[95%CI1.02-2.31],p=0.041)。癫痫发作在锁骨下/腋下(n=13,3.4%)比主动脉(n=9,1.8%)和股骨插管(n=12,1.3%,p=0.036)。主动脉插管后住院死亡率更高(主动脉:n=344,68.4%,锁骨下/腋下:n=223,56.2%,股骨:n=587,58.9%,p<0.001),如Kaplan-Meier曲线所示。总之,神经系统死亡原因(主动脉:n=12,3.9%,锁骨下/腋下:n=14,6.6%,股骨:n=28,5.0%,p=0.433)相似。
    结论:在PELS研究的分析中,锁骨下/腋下插管与较高的主要神经系统并发症和癫痫发作率相关。主动脉插管后住院死亡率较高,尽管这些患者的神经系统死亡原因发生率没有显着差异。这些结果鼓励对ECLS患者的神经系统并发症和神经监测使用保持警惕,尤其是锁骨下/腋下插管。
    BACKGROUND: Cerebral perfusion may change depending on arterial cannulation site and may affect the incidence of neurologic adverse events in post-cardiotomy extracorporeal life support (ECLS). The current study compares patients\' neurologic outcomes with three commonly used arterial cannulation strategies (aortic vs. subclavian/axillary vs. femoral artery) to evaluate if each ECLS configuration is associated with different rates of neurologic complications.
    METHODS: This retrospective, multicenter (34 centers), observational study included adults requiring post-cardiotomy ECLS between January 2000 and December 2020 present in the Post-Cardiotomy Extracorporeal Life Support (PELS) Study database. Patients with Aortic, Subclavian/Axillary and Femoral cannulation were compared on the incidence of a composite neurological end-point (ischemic stroke, cerebral hemorrhage, brain edema). Secondary outcomes were overall in-hospital mortality, neurologic complications as cause of in-hospital death, and post-operative minor neurologic complications (seizures). Association between cannulation and neurological outcomes were investigated through linear mixed-effects models.
    RESULTS: This study included 1897 patients comprising 26.5% Aortic (n = 503), 20.9% Subclavian/Axillary (n = 397) and 52.6% Femoral (n = 997) cannulations. The Subclavian/Axillary group featured a more frequent history of hypertension, smoking, diabetes, previous myocardial infarction, dialysis, peripheral artery disease and previous stroke. Neuro-monitoring was used infrequently in all groups. Major neurologic complications were more frequent in Subclavian/Axillary (Aortic: n = 79, 15.8%; Subclavian/Axillary: n = 78, 19.6%; Femoral: n = 118, 11.9%; p < 0.001) also after mixed-effects model adjustment (OR 1.53 [95% CI 1.02-2.31], p = 0.041). Seizures were more common in Subclavian/Axillary (n = 13, 3.4%) than Aortic (n = 9, 1.8%) and Femoral cannulation (n = 12, 1.3%, p = 0.036). In-hospital mortality was higher after Aortic cannulation (Aortic: n = 344, 68.4%, Subclavian/Axillary: n = 223, 56.2%, Femoral: n = 587, 58.9%, p < 0.001), as shown by Kaplan-Meier curves. Anyhow, neurologic cause of death (Aortic: n = 12, 3.9%, Subclavian/Axillary: n = 14, 6.6%, Femoral: n = 28, 5.0%, p = 0.433) was similar.
    CONCLUSIONS: In this analysis of the PELS Study, Subclavian/Axillary cannulation was associated with higher rates of major neurologic complications and seizures. In-hospital mortality was higher after Aortic cannulation, despite no significant differences in incidence of neurological cause of death in these patients. These results encourage vigilance for neurologic complications and neuromonitoring use in patients on ECLS, especially with Subclavian/Axillary cannulation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    中国大约有200万成人先天性心脏病患者,中度和重度患者的数量正在增加。然而,很少有研究调查导管插入后严重不良事件(SAE)的风险.这项研究的目的是确定与心导管插入相关的SAE的危险因素,并提供预测SAE的风险评分模型。
    回顾性收集2018年1月至2022年1月在武汉科技大学附属武汉亚洲心脏医院行心导管插入术的中重度成人先天性心脏病(ACHD)患者690例,随后分为建模组和验证组。对已识别的SAE危险因素进行了单变量分析,然后将显著因素纳入多因素logistic回归模型以筛选SAE的独立预测因子.受试者工作特性曲线(ROC)和Hosmer-Lemeshow试验用于评估模型的鉴别和校准,分别。
    符合纳入标准的690例导管插入手术中有69例(10.0%)发生SAE。建立的SAE风险计算公式为logit(p)=-6.1340.992×肺动脉高压(是)+1.459×疾病严重程度(严重)+2.324×手术类型(诊断和介入)+1.436×cTnI(≥0.028μg/L)+1.537×NT-proBNP(≥126.65pg/mL)。基于各预测因子效应大小的最终风险评分模型总分为0~7分,涉及肺动脉高压(1分),疾病严重程度(1分),程序类型(2分),cTnI(1分)和NT-proBNP(2分),得分大于3表示高风险。推导和验证队列的ROC曲线下面积的C统计量为0.840和0.911,分别。根据Hosmer-Lemeshow测试,模型组和验证组的p值分别为0.064和0.868.
    本研究建立的风险预测模型具有很高的辨别力和校准性,可为临床预测和评估中重度ACHD患者心导管术后SAE风险提供参考。
    UNASSIGNED: There are almost 2 million adult patients with congenital heart disease in China, and the number of moderate and severe patients is increasing. However, few studies have investigated the risk of serious adverse events (SAE) after catheterization among them. The aim of this study was to identify risk factors for SAE related to cardiac catheterization and to provide the risk scoring model for predicting SAE.
    UNASSIGNED: A total of 690 patients with moderate and severe adult patients with congenital heart disease (ACHD) who underwent cardiac catheterization in Wuhan Asian Heart Hospital Affiliated to Wuhan University of Science and Technology from January 2018 to January 2022 were retrospectively collected and subsequently divided into a modeling group and a verification group. A univariate analysis was performed on the identified SAE risk factors, and then significant factors were included in the multivariate logistic regression model to screen for independent predictors of SAE. The receiver operating characteristic curve (ROC) and the Hosmer-Lemeshow test were used to evaluate the discrimination and calibration of the model, respectively.
    UNASSIGNED: A SAE occurred in 69 (10.0%) of the 690 catheterization procedures meeting inclusion criteria. The established SAE risk calculation formula was logit(p) = -6.134 + 0.992 × pulmonary artery hypertension (yes) + 1.459 × disease severity (severe) + 2.324 × procedure type (diagnostic and interventional) + 1.436 × cTnI ( ≥ 0.028 μ g/L) + 1.537 × NT-proBNP ( ≥ 126.65 pg/mL). The total score of the final risk score model based on the effect size of each predictor was 0 to 7, involving pulmonary artery hypertension (1 point), disease severity (1 point), procedure type (2 points), cTnI (1 point) and NT-proBNP (2 points), and the score greater than 3 means high risk. The C-statistic of the area under the ROC curve was 0.840 and 0.911 for the derivation and validation cohorts, respectively. According to the Hosmer-Lemeshow test, the p values in the modeling group and the verification group were 0.064 and 0.868, respectively.
    UNASSIGNED: The risk prediction model developed in this study has high discrimination and calibration, which can provide reference for clinical prediction and evaluation of SAE risk after cardiac catheterization in patients with moderate and severe ACHD.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:Chiari网络,胎儿解剖结构的残余部分,由右心房内的网状结构组成。随着心脏干预的进步,与Chiari网络相关的并发症的报道越来越多.然而,在插入透析导管时,很少有关于Chiari网络中导丝或导管截留的报道.
    方法:一名患有终末期肾病的46岁男性住院,并接受了数字减影血管造影辅助的右颈内静脉隧道袖套透析导管插入术。当导丝进入约20厘米的深度时,很难推进,表现为扭转导丝时的阻力和无法进入下腔静脉。插入可剥离鞘后,很难拔出导丝。反复尝试旋转导丝后,导丝终于被拔出。纤维组织缠绕在导丝的尖端周围。它的长度是6厘米,具有光滑的表面和坚韧的纹理。我们认为我们取出的组织很可能是Chiari网络的一部分。
    结论:这个案例突出了Chiari网络使外科手术复杂化的可能性,包括导丝和导管操作困难。应该注意Chiari网络。超声心动图可用于识别Chiari网络。在手术过程中,不建议强行拉出卡住的导丝,以避免撕裂心房壁和引起心包填塞的风险。在这种情况下,与超声医生和心脏外科医生的紧急咨询可能会有所帮助。
    BACKGROUND: The Chiari network, a remnant of fetal anatomy, consists of a mesh-like structure within the right atrium. With advancements in cardiac interventions, complications associated with the Chiari network have increasingly been reported. However, there are few reports about guidewire or catheter entrapment in the Chiari network during the insertion of a dialysis catheter.
    METHODS: A 46-year-old male with end-stage renal disease was hospitalized and underwent a digital subtraction angiography-assisted catheterization of the right internal jugular vein tunnel-cuffed dialysis catheter. When the guide wire entered a depth of about 20 cm, it was difficult to advance, manifested as resistance when twisting the guide wire and inability to enter the inferior vena cava. After the peelable sheath was inserted, it was difficult to pull out the guide wire. After repeated attempts to rotate the guide wire, the guide wire was finally pulled out. A fibrous tissue was wrapped around the tip of the guide wire. Its length was 6 cm, with a smooth surface and tough texture. We considered that the tissue we pulled out was most likely a part of a Chiari network.
    CONCLUSIONS: This case highlights the potential for the Chiari network to complicate surgical procedures, including difficulty with guidewire and catheter manipulation. Attention should be paid to Chiari networks. Echocardiography can be used to identify the Chiari network. During the surgery, forcefully pulling out a stuck guidewire is not suggested, to avoid the risk of tearing the atrial wall and causing pericardial tamponade. An urgent consultation with ultrasound doctors and cardiac surgeons might be helpful in such cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号